This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: MV Ramana Reddy and His Patent on Treating RNA Virus Infections.
Introduction
MV Ramana Reddy is an inventor associated with the Icahn School of Medicine at Mount Sinai in New York, NY. His patent work concerns a potential treatment approach for RNA virus infections, including COVID-19.
Latest Patents
Reddy is listed as an inventor on 1 patent: “Use of rigosertib to treat RNA virus infections.” The patent describes methods for treating a viral infection, such as an infection caused by an RNA virus including SARS-CoV-2, or a related disease such as COVID-19. The proposed method involves administering rigosertib, or a composition containing it, to a subject, including a human patient.
Career Highlights
Reddy’s listed patent connects his work with research into therapeutic strategies for viral infections. His affiliation with the Icahn School of Medicine at Mount Sinai places this work within an academic medical research setting.
Collaborations
Premkumar Reddy and Kris White are identified as Reddy’s coworkers. Their names provide context for the research community associated with his work.
Conclusion
MV Ramana Reddy’s patent on rigosertib reflects an effort to explore treatment options for RNA virus infections and associated diseases, including COVID-19.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile